Ascellna partners with companies that offer diverse and non-overlapping solutions for drug discovery from research to clinical testing. To learn more about these services and technologies go to the Downloads page.
Primity Bio provides drug and target profiling service, cell phenotyping and signaling pathway analysis at a single cell level and across a wide range of surface markers, intracellular phosphoproteins and cytokines.
Patient-derived 3D models (PD-3DTM). Primary tissue samples are maintained in vitro in naive form for long-term analysis of therapeutic agents eﬀects on disease cells and surrounding stromal cells (bystander eﬀect).
Global CRO specialized in precision medicine: specialty lab services, advanced analyitcs and biostatisics, clinical trial services, regulatory strategy and submission, market access reimbursement, branding and marketing. Immunogenicity, immune monitoring, biobanking.
Esoteric pathology laboratory with molecular diagnostic capabilities oﬀering services to pre-clinical research. Experts in assay development, FISH, IHC, ISH.
Genome-wide functional screening and analysis to characterize cell/tissue samples, identify biomarkers, and find genetic drivers for cancer and other disease phenotypes. Our services includes RNAi and CRISPR-based genetic screens, knockout and knockdown constructs and cell lines, cell barcoding, and transcriptome profiling of cell and tissue samples.
Learn more about our Clients' Services and Technologies: